YKL-40 has been linked to a number of cardiovascular diseases including pulmonary arterial hypertension, thromboembolism, and atherosclerosis, as well as the potential use as a precursor for predicting hypertension risk25–28. Here, CHI3L1 is linked to cardiovascular disorder.